BCLI (OTC)
BRAINSTORM CELL THERAPUTC
$0.534000
-0.033000 (-5.82%)
Prev close: $0.567000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Chaim Lebovits
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $43.06M
- Employees
- 29
- P/E (TTM)
- -15.25
- P/B (TTM)
- -78.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.19 | $-0.38 | +0.1874 | +49.66% |
|
Jun 2025 (Q2)
|
$-0.34 | $-0.38 | +0.0374 | +9.91% |
|
Mar 2025 (Q1)
|
$-0.45 | $-0.99 | +0.5394 | +54.52% |
|
Dec 2024 (Q4)
|
$-0.51 | $-0.39 | -0.1224 | -31.58% |